Found: 141
Select item for more details and to access through your institution.
Evolution and implications of SARS-CoV-2 variants in the post-pandemic era.
- Published in:
- Discover Public Health, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12982-024-00140-x
- By:
- Publication type:
- Article
Screening of Omicron Virus Strain by Quantifying the Spike Protein Content.
- Published in:
- COVID, 2024, v. 4, n. 6, p. 838, doi. 10.3390/covid4060056
- By:
- Publication type:
- Article
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 767, doi. 10.1007/s15010-024-02223-y
- By:
- Publication type:
- Article
IgG antibody levels against the SARS-CoV-2 spike protein in mother–child dyads after COVID-19 vaccination.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 813, doi. 10.1007/s15010-023-02111-x
- By:
- Publication type:
- Article
Impaired immune responses and prolonged viral replication in lung allograft recipients infected with SARS-CoV-2 in the early phase after transplantation.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 847, doi. 10.1007/s15010-023-02116-6
- By:
- Publication type:
- Article
SARS-CoV-2 nucleocapsid protein, rather than spike protein, triggers a cytokine storm originating from lung epithelial cells in patients with COVID-19.
- Published in:
- Infection, 2024, v. 52, n. 3, p. 955, doi. 10.1007/s15010-023-02142-4
- By:
- Publication type:
- Article
Structural, dynamic behaviour, in-vitro and computational investigations of Schiff's bases of 1,3-diphenyl urea derivatives against SARS-CoV-2 spike protein.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-63345-9
- By:
- Publication type:
- Article
Variation in structural motifs within SARS-related coronavirus spike proteins.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 5, p. 1, doi. 10.1371/journal.ppat.1012158
- By:
- Publication type:
- Article
Correction to: Discordant Antibody and T-Cell Responses to the SARS-CoV-2 Omicron Variant in COVID-19 Messenger RNA Vaccine Recipients.
- Published in:
- 2024
- Publication type:
- Correction Notice
Identificación de la proteína "Spike" en sangre de cordón umbilical de recién nacidos de madres vacunadas contra SARS-CoV-2 durante el embarazo.
- Published in:
- Ginecología y Obstetricia de México, 2024, v. 92, n. 5, p. 189, doi. 10.24245/gom.v92i5.9201
- By:
- Publication type:
- Article
ACE2 expression and spike S1 protein‐mediated immune responses in oral mucosal cells.
- Published in:
- Oral Diseases, 2024, v. 30, n. 4, p. 2293, doi. 10.1111/odi.14670
- By:
- Publication type:
- Article
Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.
- Published in:
- Journal of Biomedical Science, 2024, v. 31, n. 1, p. 1, doi. 10.1186/s12929-024-01026-5
- By:
- Publication type:
- Article
The SARS-CoV-2 neutralizing antibody response to SD1 and its evasion by BA.2.86.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46982-6
- By:
- Publication type:
- Article
Intranasal delivery of PEA-producing Lactobacillus paracasei F19 alleviates SARS-CoV-2 spike protein-induced lung injury in mice.
- Published in:
- Translational Medicine Communications, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41231-024-00167-x
- By:
- Publication type:
- Article
Corrigendum: Corrigendum: Binding of Glycans to the SARS CoV‐2 Spike Protein, an Open Question: NMR Data on Binding Site Localization, Affinity, and Selectivity.
- Published in:
- 2024
- Publication type:
- Correction Notice
Natural products as a source of Coronavirus entry inhibitors.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2024, p. 01, doi. 10.3389/fcimb.2024.1353971
- By:
- Publication type:
- Article
Evaluation of Glutathione in Spike Protein of SARS-CoV-2 Induced Immunothrombosis and Cytokine Dysregulation.
- Published in:
- Antioxidants, 2024, v. 13, n. 3, p. 271, doi. 10.3390/antiox13030271
- By:
- Publication type:
- Article
SARS-CoV-2 Antibody Seroprevalence and Humoral Response to Vaccination in Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study.
- Published in:
- Indian Journal of Nephrology, 2024, v. 34, n. 2, p. 129, doi. 10.4103/ijn.ijn_7_23
- By:
- Publication type:
- Article
COVID‐19 vaccination: are more jabs needed or are we now immune?
- Published in:
- Internal Medicine Journal, 2024, v. 54, n. 3, p. 368, doi. 10.1111/imj.16341
- By:
- Publication type:
- Article
Disappearance of Imported Cases of Omicron Lineage BA.2.40 in West Kalimantan, Indonesia.
- Published in:
- Iranian Journal of Medical Sciences, 2024, v. 49, n. 3, p. 176, doi. 10.30476/ijms.2023.97513.2935
- By:
- Publication type:
- Article
Three-Dimensional Structural Stability and Local Electrostatic Potential at Point Mutations in Spike Protein of SARS-CoV-2 Coronavirus.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2174, doi. 10.3390/ijms25042174
- By:
- Publication type:
- Article
Precise control of digital dental unit to reduce aerosol and splatter production: new challenges for future epidemics.
- Published in:
- BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-03980-w
- By:
- Publication type:
- Article
Omicron Infections in Vaccinated Pediatric Solid Organ Transplant Recipients.
- Published in:
- Journal of the Pediatric Infectious Diseases Society, 2024, v. 13, n. 2, p. 152, doi. 10.1093/jpids/piad108
- By:
- Publication type:
- Article
Association of Nirmatrelvir/Ritonavir Treatment and COVID-19-Neutralizing Antibody Titers in a Longitudinal Health Care Worker Cohort.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 2, p. 1, doi. 10.1093/ofid/ofad625
- By:
- Publication type:
- Article
Efficient Expression in the Prokaryotic Host System, Purification and Structural Analyses of the Recombinant Human ACE2 Catalytic Subunit as a Hybrid Protein with the B Subunit of Cholera Toxin (CTB-ACE2).
- Published in:
- Protein Journal, 2024, v. 43, n. 1, p. 24, doi. 10.1007/s10930-023-10164-y
- By:
- Publication type:
- Article
Causes and Consequences of Coronavirus Spike Protein Variability.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 177, doi. 10.3390/v16020177
- By:
- Publication type:
- Article
Sotrovimab: A Review of Its Efficacy against SARS-CoV-2 Variants.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 2, p. 217, doi. 10.3390/v16020217
- By:
- Publication type:
- Article
Quantification of biases in predictions of protein–protein binding affinity changes upon mutations.
- Published in:
- Briefings in Bioinformatics, 2024, v. 25, n. 1, p. 1, doi. 10.1093/bib/bbad491
- By:
- Publication type:
- Article
Exploratory study on micronuclei and metanuclear abnormalities in exfoliated buccal cells of COVID-19 suspected patients.
- Published in:
- Journal of Cytology, 2024, v. 41, n. 1, p. 28, doi. 10.4103/joc.joc_53_23
- By:
- Publication type:
- Article
Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8 + T Cell Responses Specific for Epitopes on Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 1, p. 52, doi. 10.3390/v16010052
- By:
- Publication type:
- Article
The 2023 Nobel Prize in Physiology or Medicine.
- Published in:
- Current Science (00113891), 2023, v. 125, n. 11, p. 1168
- By:
- Publication type:
- Article
SARS-CoV-2 spike receptor-binding domain is internalized and promotes protein ISGylation in human induced pluripotent stem cell-derived cardiomyocytes.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48084-7
- By:
- Publication type:
- Article
Generation and Characterization of Monoclonal Antibodies against Swine Acute Diarrhea Syndrome Coronavirus Spike Protein.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 17102, doi. 10.3390/ijms242317102
- By:
- Publication type:
- Article
Remdesivir-Loaded Nanoliposomes Stabilized by Chitosan/Hyaluronic Acid Film with a Potential Application in the Treatment of Coronavirus Infection.
- Published in:
- Neurology International, 2023, v. 15, n. 6, p. 1320, doi. 10.3390/neurolint15040083
- By:
- Publication type:
- Article
Tubulointerstitial nephritis and uveitis syndrome and SARS-CoV-2 infection in an adolescent: just a coincidence in time?
- Published in:
- Pediatric Nephrology, 2023, v. 38, n. 12, p. 4203, doi. 10.1007/s00467-023-05950-w
- By:
- Publication type:
- Article
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43578-w
- By:
- Publication type:
- Article
No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 9, p. 1238, doi. 10.1093/cid/ciad361
- By:
- Publication type:
- Article
Molecular modeling of lupeol for antiviral activity and cellular effects.
- Published in:
- Journal of Applied Pharmaceutical Science, 2023, v. 13, n. 11, p. 131, doi. 10.7324/JAPS.2023.145048
- By:
- Publication type:
- Article
Evusheld, a SARS-CoV-2 spike protein–directed attachment inhibitor, appears in serum protein electrophoresis and immunofixation: a case study.
- Published in:
- Laboratory Medicine, 2023, v. 54, n. 6, p. e201, doi. 10.1093/labmed/lmad085
- By:
- Publication type:
- Article
Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern.
- Published in:
- BioMed Research International, 2023, p. 1, doi. 10.1155/2023/3892370
- By:
- Publication type:
- Article
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43578-w
- By:
- Publication type:
- Article
ABSTRACT.
- Published in:
- Transfusion, 2023, v. 63, p. 10A, doi. 10.1111/trf.17556
- Publication type:
- Article
Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 7, p. 950, doi. 10.1093/cid/ciad368
- By:
- Publication type:
- Article
Prevalence and risk factors of SARS-CoV-2 antibody responses among healthcare workers (June 2020–November 2021).
- Published in:
- European Journal of Public Health, 2023, v. 33, n. 5, p. 923, doi. 10.1093/eurpub/ckad093
- By:
- Publication type:
- Article
Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e930, doi. 10.1093/oncolo/oyad121
- By:
- Publication type:
- Article
A Comprehensive Analysis of Structural and Functional Changes Induced by SARS-CoV-2 Spike Protein Mutations.
- Published in:
- COVID, 2023, v. 3, n. 9, p. 1454, doi. 10.3390/covid3090100
- By:
- Publication type:
- Article
Engineers Design More Powerful RNA Vaccines.
- Published in:
- Indian Practitioner, 2023, v. 76, n. 9, p. 11
- Publication type:
- Article
Arq Ajīb – a wonder Unani formulation for inhibiting SARS-CoV-2 spike glycoprotein and main protease – an in silico approach.
- Published in:
- Journal of Complementary & Integrative Medicine, 2023, v. 20, n. 3, p. 637, doi. 10.1515/jcim-2021-0241
- By:
- Publication type:
- Article
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 560, doi. 10.1093/cid/ciad209
- By:
- Publication type:
- Article
The Role of Mast Cells and Their Inflammatory Mediators in Immunity.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 15, p. 12130, doi. 10.3390/ijms241512130
- By:
- Publication type:
- Article